New global health research hub. Korea-based vaccine developer to establish branch office in Stockholm

The international organisation IVI headquartered in Seoul, which develops vaccines for poor-country diseases, has signed a memorandum of understanding with the Swedish government on setting up a regional office in Stockholm. The office will “help Sweden and Europe create an international hub for global health research” and IVI hopes to expand its donor base.